Alzheimer Disease Clinical Trials in Baltimore, Maryland

7 studies are recruiting for alzheimer disease in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

   This open-label pilot study examines whether the hallucinogenic drug, psilocybin, given under supportive conditions, is safe and effective for depression in people with Mild Cognitive Impairment (MCI) or early Alzheimer's Disease (AD). This study will also assess whether psilocybin may improve qual…

   Stage

   EARLY_Phase 1

   Ages

   18 to 85

   Site

   Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04123314 on ClinicalTrials.gov

2. Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)

   CORT-X will examine if mitigation of stress-mediated pathogenesis of Alzheimer's disease (AD) is a feasible target for intervention in individuals at risk for this disease. This single-site (Baltimore, Maryland) phase II clinical trial is a 2-week, randomized, placebo-controlled crossover study of …

   Stage

   Phase 2

   Ages

   55 and older

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT04601038 on ClinicalTrials.gov

3. Clinical Trial on Agitation in Alzheimer's Dementia

   The purpose of this study is to assess the efficacy of the oral medication IGC-AD1, a THC-based (Delta-9-Tetrahydrocannabinol) formulation administered twice a day on Agitation in patients with mild to severe dementia from Alzheimer's.

   Stage

   Phase 2

   Ages

   60 and older

   Site

   MedStar Franklin Square Medical Center Neurology, Baltimore, Maryland

   Locations

   31 in total

   Run by

   IGC Pharma, LLC

   See if you can join NCT05543681 on ClinicalTrials.gov

4. Music Therapy for Patients With Alzheimer's Disease

   This study is designed to assess the feasibility that individualized reminiscence-based virtual music therapy sessions can enhance autobiographical memory, mood, and cognition in patients with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's Disease (AD). 60 patients with MCI or …

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05151562 on ClinicalTrials.gov

5. Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease

   The goal of this clinical trial is to learn about how genetics and the response to stress predicts cognitive decline in individuals with mild cognitive impairment. The main question[s] it aims to answer are: * Does the hormone response to acute stress predict the degree of cognitive impairment foll…

   Stage

   Not phased

   Ages

   60 and older

   Site

   Johns Hopkins School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT05795634 on ClinicalTrials.gov

6. Vestibular Therapy in Alzheimer's Disease

   Nearly 2 out of 3 patients with Alzheimer's disease (AD) experience problems with balance and mobility, which places such patients at increased risk of falling. The vestibular (inner ear balance) system plays an important role in balance stability, and vestibular therapy (VT) is well-known to impro…

   Stage

   Not phased

   Ages

   60 and older

   Site

   Johns Hopkins University School of Medicine, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT03799991 on ClinicalTrials.gov

7. HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

   This randomized controlled trial study aims to evaluate a revised hearing care intervention for older adults with Alzheimer's Disease and Related Dementias (ADRD). The community-delivered hearing care intervention utilizes tailored strategies to assess impact on communication, neuropsychiatric symp…

   Stage

   Not phased

   Ages

   60 to 100

   Site

   Johns Hopkins Memory and Alzheimer's Treatment Center, Baltimore, Maryland

   Run by

   Johns Hopkins University

   See if you can join NCT06930560 on ClinicalTrials.gov